The Efficacy of HDR Brachytherapy for Patients with Recurrent or Margin-Positive Post-Operative Basal Cell Carcinoma
Surgery is a standard treatment for patients suffering from non-melanoma skin cancer. However, postoperative relapse or positive margins after surgery are linked with worse outcome. We aimed to analyze surface high-dose-rate brachytherapy as an adjuvant/salvage option.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Tomasz Krzysztofiak, Piotr Wojcieszek Source Type: research
More News: Basal Cell Carcinoma | Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer